TRxADE HEALTH (MEDS) Competitors $3.72 -0.28 (-7.00%) As of 01/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MEDS vs. SAG, GDC, COSM, LTCH, TAIT, EDUC, HWH, UGRO, CLWT, and GWAVShould you be buying TRxADE HEALTH stock or one of its competitors? The main competitors of TRxADE HEALTH include SAG (SAG), GD Culture Group (GDC), Cosmos Health (COSM), Latch (LTCH), Taitron Components (TAIT), Educational Development (EDUC), HWH International (HWH), urban-gro (UGRO), Euro Tech (CLWT), and Greenwave Technology Solutions (GWAV). These companies are all part of the "wholesale" industry. TRxADE HEALTH vs. SAG GD Culture Group Cosmos Health Latch Taitron Components Educational Development HWH International urban-gro Euro Tech Greenwave Technology Solutions SAG (NASDAQ:SAG) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap auto/tires/trucks companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, community ranking, risk, valuation, dividends and media sentiment. Does the MarketBeat Community believe in SAG or MEDS? TRxADE HEALTH received 21 more outperform votes than SAG when rated by MarketBeat users. CompanyUnderperformOutperformSAGN/AN/ATRxADE HEALTHOutperform Votes2152.50% Underperform Votes1947.50% Which has higher earnings and valuation, SAG or MEDS? SAG has higher earnings, but lower revenue than TRxADE HEALTH. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSAGN/AN/AN/AN/AN/ATRxADE HEALTH$7.45M0.70-$17.84MN/AN/A Is SAG or MEDS more profitable? SAG has a net margin of 0.00% compared to TRxADE HEALTH's net margin of -149.81%. SAG's return on equity of 0.00% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets SAGN/A N/A N/A TRxADE HEALTH -149.81%-196.79%-112.21% Do institutionals and insiders have more ownership in SAG or MEDS? 5.7% of TRxADE HEALTH shares are owned by institutional investors. 48.4% of TRxADE HEALTH shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor SAG or MEDS? In the previous week, SAG had 1 more articles in the media than TRxADE HEALTH. MarketBeat recorded 1 mentions for SAG and 0 mentions for TRxADE HEALTH. SAG's average media sentiment score of 1.87 beat TRxADE HEALTH's score of 0.00 indicating that SAG is being referred to more favorably in the media. Company Overall Sentiment SAG Very Positive TRxADE HEALTH Neutral SummarySAG beats TRxADE HEALTH on 5 of the 9 factors compared between the two stocks. Get TRxADE HEALTH News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDS vs. The Competition Export to ExcelMetricTRxADE HEALTHDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.23M$19.37B$5.61B$9.14BDividend YieldN/A1.45%5.36%3.98%P/E RatioN/A10.5189.6917.66Price / Sales0.701.241,217.4681.09Price / CashN/A12.3044.3437.71Price / Book8.2715.875.134.73Net Income-$17.84M$776.36M$118.85M$225.42M7 Day Performance-14.87%2.16%1.40%0.75%1 Month Performance-40.00%-5.07%7.53%3.61%1 Year Performance-10.79%-13.89%26.68%21.42% TRxADE HEALTH Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDSTRxADE HEALTHN/A$3.72-7.0%N/A-14.9%$5.23M$7.45M0.0050Gap UpSAGSAGN/A$2.62+11.5%N/AN/A$25.89MN/A0.00N/AGDCGD Culture Group0.9072 of 5 stars$1.97+1.4%N/A-23.6%$21.98MN/A0.0060Short Interest ↓Gap UpCOSMCosmos Health1.5268 of 5 stars$0.86+2.7%N/A-37.0%$19.94M$53.38M-0.35100Gap DownHigh Trading VolumeLTCHLatchN/A$0.12-4.0%N/A-81.3%$19.32M$42.96M0.00420Gap UpTAITTaitron Components3.5804 of 5 stars$2.59-0.4%N/A-19.0%$15.59M$6.11M11.2610Analyst ForecastShort Interest ↓Positive NewsEDUCEducational Development0.6119 of 5 stars$1.65+1.0%N/A+6.5%$14.17M$51.03M-5.16170Analyst ForecastShort Interest ↑Gap UpHWHHWH InternationalN/A$0.39+2.3%N/A-66.1%$12.27MN/A0.00N/AShort Interest ↓Gap DownUGROurban-gro2.3527 of 5 stars$0.94-3.1%$3.25+245.4%-55.8%$11.59M$71.54M-0.69100News CoverageGap DownCLWTEuro Tech1.423 of 5 stars$1.34-3.9%N/A+0.8%$10.31M$17.94M0.0040Analyst ForecastShort Interest ↓News CoverageGWAVGreenwave Technology Solutions1.2644 of 5 stars$0.40-2.5%N/A-99.7%$8.91M$35.67M0.0090Short Interest ↓ Related Companies and Tools Related Companies SAG Competitors GD Culture Group Competitors Cosmos Health Competitors Latch Competitors Taitron Components Competitors Educational Development Competitors HWH International Competitors urban-gro Competitors Euro Tech Competitors Greenwave Technology Solutions Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MEDS) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRxADE HEALTH With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.